A Study to Evaluate of Cosmetic Benefit of a Moisturising Cream in People With Blemish Prone Skin
A Randomized, Parallel-group, Evaluator-blind, No-treatment and Positive Controlled, Single-site, Proof of Concept Clinical Study to Evaluate the Cosmetic Benefit Provided by 8 Weeks of Twice-daily Topical Application of a Developmental Moisturizing Cream With Niacinamide in Healthy Subjects With Sensitive, Oily, Blemish-prone Skin
Sponsor: GlaxoSmithKline
A NA clinical study on Skin Care, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2020 — Jan 2021 [monthly]
Completed NA
-
Jul 2018 — Mar 2020 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Completed NA
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2017 — Oct 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2017 — Jun 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
For direct contact, visit the study record on ClinicalTrials.gov .